Koujin powder (red ginseng powder) with Ninjin-youeito for fatigue due to molecular targeted therapy for advanced renal cell carcinoma
- Conditions
- advanced renal cell carcinoma
- Registration Number
- JPRN-UMIN000025391
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1) Patients who can not ingest ginseng preparations 2) Patients who have allergies to traditional Chinese medicine 3) Patients who are pregnant, have a possibility of pregnancy, are within 28 days after birth, or who are breastfeeding 4) Patients with fatigue of CTC-AE grade 3 or higher, which is the criterion for terminating molecular targeted therapeutic drugs 5) Patients who recognize the rapid progress of disease 6) Patients taking steroids, Chinese medicines and ginseng preparations, other supplements supposedly effective for fatigue within 1 month 7) Patients with hypothyroidism (FT4 0.7 or lower), patients with advanced anemia (HGB decreases by 2 or more in one month) 8) Advanced renal dysfunction, daily urine volume reduction cases 9) Patients who are judged inappropriate for the study responsible doctor or the test sharing doctor to safely carry out this test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method